Ventyx Biosciences, Inc.

NasdaqGS:VTYX Rapporto sulle azioni

Cap. di mercato: US$187.4m

Ventyx Biosciences Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Raju Mohan

Amministratore delegato

US$9.4m

Compenso totale

Percentuale dello stipendio del CEO6.3%
Mandato del CEO6yrs
Proprietà del CEO3.1%
Durata media del management2yrs
Durata media del Consiglio di amministrazione3.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully

Nov 14
We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully

Ventyx Biosciences: Ready To Escape "The Crash Cycle"

Nov 04

Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?

Jul 12
Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?

Ventyx Biosciences: Slim Chances In A Fat Market (Rating Downgrade)

Jul 01

Ventyx Pivots To Obesity Amid Transformation

Mar 12

Here's Why We're Watching Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Situation

Feb 15
Here's Why We're Watching Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Situation

Ventyx: Too Risky Right Now After Some Poor Data

Jan 18

Companies Like Ventyx Biosciences (NASDAQ:VTYX) Are In A Position To Invest In Growth

Sep 21
Companies Like Ventyx Biosciences (NASDAQ:VTYX) Are In A Position To Invest In Growth

Ventyx Biosciences (NASDAQ:VTYX) Is In A Good Position To Deliver On Growth Plans

Jun 07
Ventyx Biosciences (NASDAQ:VTYX) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

Feb 20
We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

Ventyx Biosciences: Not Chasing This Rally

Sep 18

We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Aug 19
We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Ventyx Biosciences GAAP EPS of -$0.39 beats by $0.06

Aug 15

Ventyx Biosciences autoimmune/autoinflammatory candidate meets phase 1 goals

Jun 29

We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

May 06
We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Jan 21
We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Raju Mohan rispetto agli utili di Ventyx Biosciences?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$153m

Jun 30 2024n/an/a

-US$171m

Mar 31 2024n/an/a

-US$193m

Dec 31 2023US$9mUS$596k

-US$193m

Sep 30 2023n/an/a

-US$181m

Jun 30 2023n/an/a

-US$158m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$4mUS$567k

-US$108m

Sep 30 2022n/an/a

-US$91m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$69m

Dec 31 2021US$15mUS$423k

-US$85m

Sep 30 2021n/an/a

-US$84m

Jun 30 2021n/an/a

-US$79m

Mar 31 2021n/an/a

-US$65m

Dec 31 2020US$68kUS$37k

-US$28m

Compensazione vs Mercato: La retribuzione totale di Raju ($USD 9.41M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.45M ).

Compensazione vs guadagni: La retribuzione di Raju è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Raju Mohan (66 yo)

6yrs

Mandato

US$9,411,949

Compensazione

Dr. Raju S. Mohan, Ph.D. founded Ventyx Biosciences, Inc. in November 2018 and serves as its Chief Executive Officer and Director since then and serves as its President since November 22, 2023. Dr. Mohan h...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Sheila Gujrathi
Executive Chairperson3.5yrsUS$486.29k0%
$ 0
Raju Mohan
Founder6yrsUS$9.41m3.08%
$ 5.8m
John Nuss
Chief Scientific Officer5.8yrsUS$3.89m0.37%
$ 702.2k
Roy Gonzales
Interim Principal Financial Officer & Principal Accounting Officerless than a yearNessun dato0.0010%
$ 2.0k
Matthew Moore
Chief Operating Officerless than a yearNessun datoNessun dato
Mark Forman
Chief Medical Officerless than a yearNessun datoNessun dato

2.0yrs

Durata media

56yo

Età media

Gestione esperta: Il team dirigenziale di VTYX è considerato esperto (durata media dell'incarico 2 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Sheila Gujrathi
Executive Chairperson3.5yrsUS$486.29k0%
$ 0
Raju Mohan
Founder6yrsUS$9.41m3.08%
$ 5.8m
Allison Hulme
Independent Director1.8yrsUS$834.42k0%
$ 0
Somasundaram Subramaniam
Independent Director6yrsUS$417.35kNessun dato
Alexa Kimball
Member of Clinical & Scientific Advisory Boardno dataNessun datoNessun dato
James Krueger
Member of Clinical & Scientific Advisory Boardno dataNessun datoNessun dato
Bruce Sands
Member of Clinical & Scientific Advisory Boardno dataNessun datoNessun dato
Emma Guttman-Yassky
Member of Clinical & Scientific Advisory Boardno dataNessun datoNessun dato
William White
Independent Director3.5yrsUS$416.29k0%
$ 0
Onaiza Cadoret-Manier
Independent Director1.8yrsUS$837.34k0%
$ 0

3.5yrs

Durata media

60.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di VTYX sono considerati esperti (durata media dell'incarico 3.5 anni).